MOLECULAR VISION

Scope & Guideline

Advancing ocular health through innovative research.

Introduction

Explore the comprehensive scope of MOLECULAR VISION through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore MOLECULAR VISION in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1090-0535
PublisherMOLECULAR VISION
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1995 to 2024
AbbreviationMOL VIS / Mol. Vis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressC/O JEFF BOATRIGHT, LAB B, 5500 EMORY EYE CENTER, 1327 CLIFTON RD, N E, ATLANTA, GA 30322

Aims and Scopes

Molecular Vision is a journal dedicated to the dissemination of research in the field of vision science, particularly focusing on the molecular and cellular mechanisms underlying ocular health and disease. The journal aims to provide a platform for innovative research that contributes to the understanding of the pathophysiology of eye diseases and the development of therapeutic strategies.
  1. Molecular Mechanisms in Ocular Diseases:
    The journal publishes research that explores the molecular and cellular basis of various ocular diseases, such as retinitis pigmentosa, diabetic retinopathy, and glaucoma, emphasizing the genetic and biochemical pathways involved.
  2. Innovative Therapeutic Approaches:
    Molecular Vision highlights studies that investigate novel treatment modalities, including gene therapy, stem cell therapy, and pharmacological interventions aimed at restoring vision or preventing vision loss.
  3. Technological Advances in Ocular Research:
    The journal focuses on advancements in imaging technologies, such as optical coherence tomography (OCT) and confocal microscopy, which are essential for visualizing ocular structures and understanding disease progression.
  4. Genetic Studies and Biomarkers:
    Research involving genetic mutations, polymorphisms, and their associations with ocular diseases is prominent, with an emphasis on identifying potential biomarkers for early diagnosis and treatment efficacy.
  5. Inflammatory and Oxidative Stress Responses:
    The journal covers studies that investigate the role of inflammation and oxidative stress in ocular diseases, providing insights into potential therapeutic targets.
Molecular Vision has shown a dynamic evolution in its focus areas, with several emerging themes gaining traction in recent publications. These trends reflect the journal's commitment to addressing contemporary challenges in vision science and ocular health.
  1. Genetic and Genomic Research:
    There is a growing emphasis on genetic studies, including whole exome and genome sequencing, which aim to uncover novel mutations associated with inherited retinal diseases and other ocular conditions.
  2. Molecular Pathways in Disease:
    Research exploring specific molecular pathways, such as the PI3K/Akt pathway and oxidative stress mechanisms, is increasingly common, highlighting the importance of understanding disease mechanisms at a molecular level.
  3. Biomarkers and Precision Medicine:
    The identification of biomarkers for early detection and monitoring of ocular diseases is a prominent trend, with studies focusing on the proteomic and metabolomic profiles of aqueous humor and retinal tissues.
  4. Innovations in Imaging and Monitoring:
    Advanced imaging techniques, including OCT angiography and in vivo confocal microscopy, are gaining popularity for their ability to monitor disease progression and treatment responses in real-time.
  5. Therapeutic Applications of Stem Cells and Regenerative Medicine:
    There is an emerging interest in the application of stem cell therapies and regenerative approaches to treat ocular diseases, reflecting a shift towards innovative treatment strategies.

Declining or Waning

While Molecular Vision continues to thrive in various research domains, certain themes have seen a decline in frequency and emphasis in recent publications. This shift may reflect changing research priorities or advancements in technology and understanding.
  1. Traditional Histopathology Studies:
    Research focused solely on traditional histopathological techniques has decreased, as more studies now incorporate advanced molecular techniques and imaging methods to gain deeper insights into ocular pathologies.
  2. Basic Animal Models:
    There is a noticeable reduction in studies using basic animal models without clear translational relevance. Recent publications favor more sophisticated models that better mimic human disease conditions.
  3. Non-Molecular Therapeutic Approaches:
    Research focusing on conventional therapeutic approaches without molecular or genetic underpinnings has waned, as the field shifts towards precision medicine and targeted therapies.
  4. General Ocular Epidemiology:
    While epidemiological studies are essential, there has been a decrease in general studies that do not incorporate molecular data or genetic analysis, reflecting a trend towards integrating molecular insights into epidemiological research.

Similar Journals

EUROPEAN JOURNAL OF OPHTHALMOLOGY

Shaping the Future of Eye Care and Research
Publisher: SAGE PUBLICATIONS LTDISSN: 1120-6721Frequency: 6 issues/year

The EUROPEAN JOURNAL OF OPHTHALMOLOGY, published by SAGE PUBLICATIONS LTD, is a leading international journal in the field of ophthalmology, dedicated to advancing the understanding and treatment of ocular diseases and disorders. With an ISSN of 1120-6721 and an E-ISSN of 1724-6016, the journal aims to provide a platform for innovative research, critical reviews, and comprehensive studies that span the diverse aspects of the discipline. As part of its commitment to disseminating high-quality research, the journal is indexed in Scopus, achieving an impressive rank of #47 out of 137 in the Medicine - Ophthalmology category, indicating its strong impact within the academic community. With a current impact factor that places it in the Q2 quartile for both Medicine (miscellaneous) and Ophthalmology as of 2023, it offers researchers and practitioners access to important findings and developments in eye health. The journal's converged years from 1991 to 2024 exemplify its longstanding commitment to the field, making it an essential resource for anyone looking to stay at the forefront of ophthalmological research.

EXPERIMENTAL EYE RESEARCH

Pioneering Insights into Eye Function and Disorders
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 0014-4835Frequency: 12 issues/year

EXPERIMENTAL EYE RESEARCH, published by Academic Press Ltd - Elsevier Science Ltd, is a preeminent journal dedicated to advancing the fields of ophthalmology and neuroscience. With a history of insightful publications dating back to 1961, this journal serves as a critical platform for researchers, professionals, and students interested in the cellular and molecular mechanisms underlying visual processes. The journal boasts impressive rankings, including being placed in the top quartile (Q1) of both the Ophthalmology and Sensory Systems categories, and is recognized in the 2nd quartile (Q2) for Cellular and Molecular Neuroscience. With an impact factor reflecting its significant contribution to the field, EXPERIMENTAL EYE RESEARCH is a valuable resource that promotes the exchange of innovative research and ideas essential for understanding the complexities of eye function and vision-related disorders. Researchers looking to publish their findings or stay abreast of the latest studies will find this journal a vital component of their academic toolkit.

JAMA Ophthalmology

Illuminating the Path to Better Vision
Publisher: AMER MEDICAL ASSOCISSN: 2168-6165Frequency: 12 issues/year

JAMA Ophthalmology, the premier journal in the field of ophthalmology, is published by the esteemed American Medical Association. Renowned for its rigorous peer-review process and commitment to advancing eye health research, JAMA Ophthalmology holds a prestigious position in the scientific community, boasting an impressive impact factor and ranking as Q1 in the category of Ophthalmology. With a Scopus rank of #3 out of 137 in its field and a remarkable 98th percentile, the journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to the ophthalmic sciences. Readers can explore a wealth of cutting-edge findings, clinical studies, and review articles that not only contribute to the sustainable advancement of ophthalmic knowledge but also foster innovative approaches in patient care. As we converge into 2024, the journal continues to embrace open access principles, ensuring that groundbreaking research is readily available to a global audience, enhancing collaborative efforts and furthering the development of the ophthalmology discipline.

Journal of Optometry

Elevating optometric knowledge through open access.
Publisher: ELSEVIERISSN: 1888-4296Frequency: 4 issues/year

The Journal of Optometry, published by Elsevier, is a leading open access journal dedicated to advancing the field of optometry and vision science. With an ISSN of 1888-4296 and an E-ISSN of 1989-1342, this journal serves as a pivotal platform for researchers, practitioners, and academics alike to disseminate and engage with high-quality original research and review articles. As of 2023, the journal holds an impressive Q2 ranking in the Optometry category, demonstrating its influence and relevance, particularly as it ranks #2 out of 12 in the Health Professions - Optometry category on Scopus with an 87th percentile. Since becoming open access in 2008, the Journal of Optometry has prioritized accessibility and the exchange of ideas, enriching the scholarly community and enhancing practical application in clinical settings. The journal welcomes submissions that push the boundaries of ocular research, clinical practices, and the education of optometry professionals, making it an essential resource for anyone invested in the future of eye health.

International Journal of Ophthalmology

Elevating Ophthalmic Science for a Brighter Future
Publisher: IJO PRESSISSN: 2222-3959Frequency: 12 issues/year

The International Journal of Ophthalmology, with ISSN 2222-3959 and E-ISSN 2227-4898, is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by IJO PRESS in China, this journal has been a valuable resource since its inception in 2005, providing a platform for groundbreaking research and clinical studies in ophthalmic science. With an impressive Q2 ranking in the 2023 Ophthalmology category and a Scopus rank of #65 out of 137, the journal consistently showcases high-quality articles that contribute significantly to the understanding and treatment of eye diseases. Since adopting an open-access model in 2010, it has expanded its reach, allowing researchers, professionals, and students worldwide to access vital knowledge in the field. The journal aims to bridge the gap between laboratory research and clinical practice, making it an essential resource for those committed to improving visual health and advancing ophthalmologic education and innovation.

Translational Vision Science & Technology

Connecting Science and Technology for Visual Health
Publisher: ASSOC RESEARCH VISION OPHTHALMOLOGY INCISSN: 2164-2591Frequency: 6 issues/year

Translational Vision Science & Technology is a premier open access journal dedicated to the advancement of the field of ophthalmology and biomedical engineering. Published by the Association for Research in Vision and Ophthalmology, Inc., this journal has established itself as a leading source of high-quality research since its inception in 2013, achieving a remarkable impact factor reflective of its influential contribution to the field. With an impressive ranking of #21 in Ophthalmology and #120 in Biomedical Engineering within the Scopus database, it sits within the prestigious Q1 quartile for both categories as of 2023, further validating its significance. The journal's scope encompasses a wide variety of topics focused on the intersection of ophthalmological science and technological innovation, welcoming contributions that promote the understanding and treatment of visual disorders. Available as an Open Access publication since 2016, it ensures that cutting-edge research is freely accessible to researchers, practitioners, and students worldwide, facilitating the rapid dissemination of knowledge essential for the advancement of vision science.

Journal of Ophthalmic Inflammation and Infection

Advancing ocular health through cutting-edge research.
Publisher: SPRINGERISSN: 1869-5760Frequency: 1 issue/year

The Journal of Ophthalmic Inflammation and Infection, published by SPRINGER since 2011, stands as a pivotal resource for professionals in the fields of ophthalmology and infectious diseases. With an impactful Q2 ranking in both categories as of 2023, this open access journal is dedicated to disseminating high-quality research and reviews related to ocular inflammation and its infectious causes, fostering a deeper understanding of these critical health issues. The journal is well-regarded in the academic community, currently positioned at Rank #43 in Ophthalmology, reflecting its significance and influence within the discipline. The journal is accessible globally from its base in Germany, offering valuable insights to researchers, healthcare professionals, and students alike. With a commitment to excellence in publishing through 2024 and beyond, this journal continues to contribute meaningfully to innovative studies and clinical practices in ocular health.

CURRENT EYE RESEARCH

Pioneering Research for a Brighter Vision
Publisher: TAYLOR & FRANCIS INCISSN: 0271-3683Frequency: 12 issues/year

CURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

Unveiling discoveries in ophthalmology.
Publisher: ASSOC RESEARCH VISION OPHTHALMOLOGY INCISSN: 0146-0404Frequency: 12 issues/year

Investigative Ophthalmology & Visual Science (IOVS) is a leading academic journal published by the Association for Research in Vision and Ophthalmology, dedicated to advancing the field of ophthalmology and visual science. With an impressive impact factor and ranking in the Q1 category for both Ophthalmology and Sensory Systems, IOVS is well-respected for disseminating cutting-edge research and innovative discoveries. Established in 1977, this Open Access journal allows for broad accessibility to pioneering studies, fostering collaboration among researchers, clinicians, and students. The journal has consistently maintained high visibility in the academic community, evidenced by its robust rankings in Scopus, including Rank #16 in Ophthalmology. As it continues to pave the way for future developments in the understanding and treatment of ocular diseases, IOVS serves as an invaluable resource for those immersed in the complex field of visual science.

OPHTHALMOLOGICA

Advancing Vision Science Through Rigorous Research
Publisher: KARGERISSN: 0030-3755Frequency: 6 issues/year

OPHTHALMOLOGICA is a prestigious journal published by KARGER, dedicated to the dynamic field of ophthalmology and its interdisciplinary connections with medicine and sensory systems. With a rich history spanning over a century since its inception in 1899, this journal is esteemed for its high-quality research and impactful contributions, maintaining an impressive Q1 quartile ranking in both ophthalmology and miscellaneous medicine as of 2023, alongside a notable Q2 status in sensory systems. The journal's influence is reinforced by its Scopus rankings, where it ranks 26th out of 137 in ophthalmology, showcasing a strong percentile position of 81. Based in Basel, Switzerland, OPHTHALMOLOGICA serves as an essential platform for researchers, professionals, and students, providing essential insights, reviews, and studies that push the boundaries of knowledge in the vision sciences. Although it does not currently offer open access, its contributions are critical for those pursuing advancements in ocular health and related disciplines.